Pathophysiologically based drug treatment of sickle cell disease
MH Steinberg - Trends in Pharmacological Sciences, 2006 - cell.com
Sickle cell disease is a systemic disorder that is caused by a mutation (Glu6Val) in the gene
that encodes β globin. The sickle hemoglobin molecule (HbS) is a tetramer of two α-globin …
that encodes β globin. The sickle hemoglobin molecule (HbS) is a tetramer of two α-globin …
Pathophysiologically based drug treatment of sickle cell disease.
MH Steinberg - Trends in Pharmacological Sciences, 2006 - europepmc.org
Sickle cell disease is a systemic disorder that is caused by a mutation (Glu6Val) in the gene
that encodes beta globin. The sickle hemoglobin molecule (HbS) is a tetramer of two alpha …
that encodes beta globin. The sickle hemoglobin molecule (HbS) is a tetramer of two alpha …
Pathophysiologically based drug treatment of sickle cell disease
MH Steinberg - Trends in pharmacological sciences, 2006 - pubmed.ncbi.nlm.nih.gov
Sickle cell disease is a systemic disorder that is caused by a mutation (Glu6Val) in the gene
that encodes beta globin. The sickle hemoglobin molecule (HbS) is a tetramer of two alpha …
that encodes beta globin. The sickle hemoglobin molecule (HbS) is a tetramer of two alpha …
Pathophysiologically based drug treatment of sickle cell disease
MH Steinberg - Trends in Pharmacological Sciences, 2006 - Elsevier
Sickle cell disease is a systemic disorder that is caused by a mutation (Glu6Val) in the gene
that encodes β globin. The sickle hemoglobin molecule (HbS) is a tetramer of two α-globin …
that encodes β globin. The sickle hemoglobin molecule (HbS) is a tetramer of two α-globin …
Hemoglobins
MH Steinberg - Trends in Pharmacological Sciences, 2006 - infona.pl
Sickle cell disease is a systemic disorder that is caused by a mutation (Glu6Val) in the gene
that encodes β globin. The sickle hemoglobin molecule (HbS) is a tetramer of two α-globin …
that encodes β globin. The sickle hemoglobin molecule (HbS) is a tetramer of two α-globin …